V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310008370 | 310005542 | 1.85 | 73.3 | Neo-adjuvant (N) | 2018-07-21 | 2018-07-28 | CYCLOPHOSPHAMIDE + ETOPOSIDE + LOMUSTINE | N | N | 310014344 | EP |
| 310008371 | 310005543 | 1.63 | 0 | null | 2018-01-16 | 2018-01-16 | BCG Intravesical | 02 | N | 310014792 | RMS 2005 TRIAL |
| 310008372 | 310005543 | null | 77.7 | Curative (C) | 2015-06-11 | 2015-06-18 | ECX | 02 | N | 310014792 | PEG INTERFERON |
| 310008373 | 310005543 | 1.73 | 106.4 | Palliative (P) | 2017-07-18 | 2017-07-18 | ECHELON-2 TRIAL | N | N | 310014792 | CHLORAMBUCIL + DEXAMETHASONE + ETOPOSIDE |
| 310008374 | 310008456 | 1.77 | 83.2 | Curative (C) | 2015-01-18 | 2015-02-02 | Carboplatin + Docetaxel | N | N | 310015053 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 310008375 | 310005546 | 0 | 69.6 | Palliative (P) | 2014-02-05 | 2014-05-29 | Lenalidomide Cycle 26 onwards (PAS) | 01 | N | 310015515 | ALEMTUZUMAB |
| 310008376 | 310005547 | null | 8.9 | Palliative (P) | 2017-06-03 | 2017-06-04 | Dacarbazine | 02 | N | 310015715 | CAPECITABINE |
| 310008377 | 310005548 | null | 72.5 | Palliative (P) | 2016-03-28 | 2016-05-04 | DHAP - R | 02 | N | 310015779 | RMS 2005 TRIAL |
| 310008378 | 310005549 | 1.76 | null | Curative (C) | 2015-01-15 | 2015-01-24 | Cetuximab 7 day (Cycle 1) | N | null | 310015779 | METHOTREXATE |
| 310008379 | 310005550 | 1.71 | 86.2 | Palliative (P) | 2016-12-06 | 2016-12-08 | Oxaliplatin + Modified de Gramont | N | N | 310016151 | ALL INTENSIFICATION |
| 310008380 | 310008460 | 1.96 | 58.1 | Palliative (P) | 2014-04-29 | 2014-06-19 | THALIDOMIDE | N | N | 310016194 | METHOTREXATE HIGH DOSE |
| 310008381 | 310008460 | 1.53 | 80 | Curative (C) | 2016-04-21 | 2016-05-31 | Cisplatin + Topotecan | 2 | N | 310016194 | DOXORUBICIN |
| 310008382 | 310005551 | 1.63 | 12.2 | null | 2016-12-08 | 2017-06-24 | RCEOP | N | null | 310016402 | RMS 2005 TRIAL |
| 310008383 | 310005552 | null | null | Curative (C) | 2018-03-26 | 2018-04-24 | CARBOPLATIN + RT | 02 | N | 310016444 | BCG |
| 310008384 | 310005552 | 1.76 | 66.6 | Palliative (P) | 2016-12-23 | 2017-01-08 | ICE + GCSF | N | N | 310016444 | VINBLASTINE |
| 310008385 | 310005553 | 1.68 | 62.6 | Palliative (P) | 2014-04-13 | 2014-04-14 | Retinoblastoma JOE | 2 | N | 310016521 | LANREOTIDE |
| 310008386 | 310005554 | 1.76 | 92.2 | null | 2016-01-11 | 2016-01-11 | CVP R | N | N | 310016998 | ALEMTUZUMAB |
| 310008387 | 310005555 | 1.48 | 0 | Curative (C) | 2016-11-02 | 2016-11-09 | CAV | N | N | 310017023 | BENDAMUSTINE + RITUXIMAB |
| 310008388 | 310005556 | 1.61 | 71 | Curative (C) | 2016-04-01 | 2016-04-07 | DHAP | 2 | N | 310017288 | NIVOLUMAB |
| 310008389 | 310005556 | 1.77 | 93.3 | Palliative (P) | 2019-03-05 | 2019-03-05 | Methotrexate High Dose (3g/m2) | N | N | 310017288 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310008390 | 310005558 | 1.75 | 50 | null | 2017-09-18 | 2017-11-04 | STS Rhabdomyosarcoma RMS 2005 IVA | 02 | N | 310018382 | ATG |
| 310008391 | 310005561 | 1.7 | 76.3 | Adjuvant (A) | 2018-03-26 | 2018-04-04 | ICE | N | N | 310018395 | CARBOPLATIN + DOCETAXEL |
| 310008392 | 310005562 | 0 | null | Curative (C) | 2016-12-25 | 2017-02-10 | Methotrexate High Dose (3g/m2) | 2 | N | 310018549 | CYTARABINE + ETOPOSIDE + MELPHALAN + THIOTEPA |
| 310008393 | 310005563 | 1.67 | 50.8 | Curative (C) | 2016-08-15 | 2016-08-15 | CISPLATIN + ETOPOSIDE | 2 | N | 310018611 | IRINOTECAN + MDG |
| 310008394 | 310005563 | null | 49.8 | Palliative (P) | 2015-03-06 | 2015-03-10 | Capecitabine | N | N | 310018611 | EPIRUBICIN |
| 310008395 | 310005564 | null | 71 | Curative (C) | null | 2018-01-06 | CARBOPLATIN + FLUOROURACIL | 02 | N | 310018837 | PACMEL TRIAL |
| 310008396 | 310005565 | null | 84.8 | Palliative (P) | 2015-02-17 | 2015-10-11 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 310018979 | NIVOLUMAB |
| 310008397 | 310005566 | 1.57 | 64.1 | Curative (C) | 2014-07-21 | 2014-09-25 | TRASTUZUMAB | 02 | N | 310019072 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 310008398 | 310005568 | 1.82 | 98 | Palliative (P) | null | 2018-08-24 | Sunitinib | 2 | N | 310019434 | SELPAC TRIAL |
| 310008399 | 310005568 | 1.61 | 60.2 | Palliative (P) | 2018-02-18 | 2018-08-12 | CVD | N | N | 310019434 | BEVACIZUMAB + CARBO |
| 310008400 | 310005569 | 1.62 | 13.1 | Palliative (P) | 2018-03-03 | 2018-03-05 | R-EPOCH | N | null | 310020027 | BLEOMYCIN + CARBOPLATIN + ETOPOSIDE |
| 310008401 | 310010015 | 1.84 | 1 | Curative (C) | 2016-06-06 | 2016-11-18 | Atezolizumab | 02 | N | 310020027 | ALL INTERIM GUIDELINES |
| 310008402 | 310008471 | 1.82 | 99.8 | Curative (C) | 2013-10-15 | 2015-02-25 | Capecitabine | N | N | 310020428 | CAPECITABINE + OXALIPLATIN |
| 310008403 | 310011338 | null | null | null | 2016-03-17 | 2016-07-02 | Oxaliplatin + Modified de Gramont | 2 | null | 310020916 | BEVACIZUMAB + TEMOZOLOMIDE |
| 310008404 | 310011338 | 1.59 | 67 | Curative (C) | 2016-09-24 | 2016-09-26 | IVE + METHOTREXATE | 02 | N | 310020916 | GEMCITABINE + TREOSULPHAN |
| 310008405 | 310005572 | 1.67 | null | Curative (C) | 2017-04-09 | 2017-04-11 | Irinotecan + Modified De Gramont | N | N | 310021204 | CARBOPLATIN + ETOPOSIDE + THIOTEPA |
| 310008406 | 310010017 | 1.7 | null | Palliative (P) | 2014-11-28 | 2014-12-08 | CVD | N | Y | 310021296 | CISPLATIN + FLUOROURACIL |
| 310008407 | 310005575 | 1.63 | 10.7 | Disease modification (D) | 2018-05-11 | 2018-05-16 | IPILIMUMAB + NIVOLUMAB | N | N | 310021313 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 310008408 | 310008473 | 1.48 | 67 | Curative (C) | 2017-05-17 | 2017-05-23 | Sunitinib | 02 | N | 310021471 | OXALIPLATIN + MDG |
| 310008409 | 310005579 | 1.8 | 61.9 | Palliative (P) | 2014-11-02 | 2014-11-09 | ICE | N | N | 310021589 | IPILIMUMAB + NIVOLUMAB |
| 310008410 | 310005582 | 1.69 | 103 | Curative (C) | 2016-01-31 | 2016-02-07 | Oxaliplatin + Modified de Gramont | 2 | N | 310021737 | TRIPLE INTRATHECAL |
| 310008411 | 310005583 | 1.8 | 93 | Curative (C) | 2014-02-06 | 2015-04-28 | Methotrexate 10mg/m2 po 7day | 02 | N | 310021779 | CYTARABINE HD + METHOTREXATE HD |
| 310008412 | 310008477 | 1.7 | 77.9 | Curative (C) | null | 2016-12-30 | CVP R | 01 | N | 310021779 | BCG |
| 310008413 | 310005584 | 1.68 | 10.7 | Disease modification (D) | 2015-12-26 | 2015-12-26 | Bevacizumab + CARBOPLATIN + GEMCITABINE | 02 | N | 310022131 | NIRAPARIB |
| 310008414 | 310005585 | 1.54 | 41.3 | Palliative (P) | 2016-09-22 | 2016-09-26 | ABVD | N | N | 310022160 | HYDROXYCARBAMIDE |
| 310008415 | 310005585 | 1.6 | 85 | Palliative (P) | 2015-11-19 | 2015-11-19 | Cisplatin + Etoposide (5 day) | 2 | N | 310022160 | ETOPOSIDE + IFOSFAMIDE + RITUXIMAB |
| 310008416 | 310005587 | 0 | 78.8 | Palliative (P) | 2017-12-17 | 2017-12-17 | Doxorubicin 75mg/m2 | 2 | N | 310022335 | TRABECTEDIN |
| 310008417 | 310010023 | 1.79 | 0 | Disease modification (D) | 2017-02-05 | 2017-02-13 | CARBOPLATIN + RT | 2 | N | 310022506 | CERITINIB |
| 310008418 | 310005590 | 1.6 | 69.5 | Curative (C) | 2014-06-02 | 2014-06-04 | BCG Intravesical | Y | null | 310022528 | GEMCITABINE + VINORELBINE |
| 310008419 | 310005591 | 1.95 | 66 | Palliative (P) | 2014-07-31 | 2014-08-03 | R-GDP | N | N | 310022562 | GEMCITABINE + OXALIPLATIN |